Pioglitazone use and risk of bladder cancer: a systematic literature review and meta-analysis of observational studies-Reference-Cited by-同舟云学术

Pioglitazone use and risk of bladder cancer: a systematic literature review and meta-analysis of observational studies

Published:2018-06-14 Issue:1 Volume:10 Page:24-36
ISSN:2190-1678
Container-title:Diabetology International
language:en
Short-container-title:Diabetol Int

Author:

Mehtälä Juha,Khanfir Houssem,Bennett Dimitri,Ye Yizhou,Korhonen Pasi,Hoti Fabian^ORCID

Funder

Takeda Pharmaceuticals U.S.A.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/article/10.1007/s13340-018-0360-4/fulltext.html

Reference48 articles.

1. World Health Organization. Global Report on Diabetes. 2016. http://apps.who.int/iris/bitstream/10665/204871/1/9789241565257_eng.pdf?ua=1 . Accessed 23 Aug 2016.

2. Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf . Accessed 23 Aug 2016.

3. American Diabetes Association. Economic Costs of Diabetes in the US in 2012. Diabetes Care. 2013;36:1033–46. https://doi.org/10.2337/dc12-2625 .

4. DeFronzo RA, Banerji M, Bray GA, et al. Actos now for the prevention of diabetes (ACT NOW) study. BMC Endocr Disord. 2009. https://doi.org/10.1186/1472-6823-9-17 .

5. DeFronzo RA, Tripathy D, Schwenke DC, et al. Pioglitazone for diabetes prevention in impaired glucose tolerance. N Engl J Med. 2011;364:1104–15. https://doi.org/10.1056/NEJMoa1010949 .

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view;Journal of Endocrinological Investigation;2024-06-27

2. Diabetes mellitus and cancer;Cardiovascular Prevention and Pharmacotherapy;2023-07-31

3. An international multidisciplinary consensus statement on MAFLD and the risk of CVD;Hepatology International;2023-05-19

4. Diabetes and Cancer;The Journal of Korean Diabetes;2023-03-31

5. Urothelkarzinom der Harnblase: Epidemiologie, Ätiologie und Risikofaktoren;Die Urologie;2023